News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market



3/28/2008 9:13:13 AM

PALM BEACH GARDENS, FL--(Marketwire - March 27, 2008) - Pegasus Pharmaceuticals (PINKSHEETS: PGUZ) today announced that it has filed for patents for its innovative biological product, MOLD GONE™. Pegasus is engaged in the research, development and marketing of anti-microbial compositions and systems for killing, inhibiting and growth prevention of fungal matter such as live cells, spores and mycotoxins associated with molds.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES